ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 58 filers reported holding ONCOCYTE CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $304 | -99.7% | 1,323 | -97.8% | 0.00% | – |
| Q1 2022 | $90,000 | -28.0% | 60,355 | +5.0% | 0.00% | – |
| Q4 2021 | $125,000 | -44.2% | 57,500 | -8.7% | 0.00% | – |
| Q3 2021 | $224,000 | -41.8% | 62,989 | -6.1% | 0.00% | -100.0% |
| Q2 2021 | $385,000 | +45.3% | 67,116 | +31.5% | 0.00% | – |
| Q1 2021 | $265,000 | +136.6% | 51,024 | +8.4% | 0.00% | – |
| Q4 2020 | $112,000 | +138.3% | 47,070 | +38.3% | 0.00% | – |
| Q3 2020 | $47,000 | -33.8% | 34,040 | -8.2% | 0.00% | – |
| Q2 2020 | $71,000 | +61.4% | 37,098 | +108.1% | 0.00% | – |
| Q1 2020 | $44,000 | +10.0% | 17,830 | 0.0% | 0.00% | – |
| Q4 2019 | $40,000 | +8.1% | 17,830 | 0.0% | 0.00% | – |
| Q3 2019 | $37,000 | -17.8% | 17,830 | -1.1% | 0.00% | – |
| Q2 2019 | $45,000 | – | 18,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |